153 related articles for article (PubMed ID: 23412784)
1. The use of cytogenetic microarrays in myelodysplastic syndrome characterization.
Shaffer LG; Ballif BC; Schultz RA
Methods Mol Biol; 2013; 973():69-85. PubMed ID: 23412784
[TBL] [Abstract][Full Text] [Related]
2. Microarray-based comparative genomic hybridization of cancer targets reveals novel, recurrent genetic aberrations in the myelodysplastic syndromes.
Kolquist KA; Schultz RA; Furrow A; Brown TC; Han JY; Campbell LJ; Wall M; Slovak ML; Shaffer LG; Ballif BC
Cancer Genet; 2011 Nov; 204(11):603-28. PubMed ID: 22200086
[TBL] [Abstract][Full Text] [Related]
3. Combined comparative genomic hybridization and single-nucleotide polymorphism array detects cryptic chromosomal lesions in both myelodysplastic syndromes and cytopenias of undetermined significance.
Evans AG; Ahmad A; Burack WR; Iqbal MA
Mod Pathol; 2016 Oct; 29(10):1183-99. PubMed ID: 27389314
[TBL] [Abstract][Full Text] [Related]
4. Single nucleotide polymorphism array karyotyping: a diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytogenetic testing.
Arenillas L; Mallo M; Ramos F; Guinta K; Barragán E; Lumbreras E; Larráyoz MJ; De Paz R; Tormo M; Abáigar M; Pedro C; Cervera J; Such E; José Calasanz M; Díez-Campelo M; Sanz GF; Hernández JM; Luño E; Saumell S; Maciejewski J; Florensa L; Solé F
Genes Chromosomes Cancer; 2013 Dec; 52(12):1167-77. PubMed ID: 24123380
[TBL] [Abstract][Full Text] [Related]
5. Detection of cryptic chromosomal lesions including acquired segmental uniparental disomy in advanced and low-risk myelodysplastic syndromes.
Gondek LP; Haddad AS; O'Keefe CL; Tiu R; Wlodarski MW; Sekeres MA; Theil KS; Maciejewski JP
Exp Hematol; 2007 Nov; 35(11):1728-38. PubMed ID: 17920760
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of previously cryptic copy number alterations and loss of heterozygosity in pediatric acute myeloid leukemia and myelodysplastic syndrome determined using combined array comparative genomic hybridization plus single-nucleotide polymorphism microarray analyses.
Koh KN; Lee JO; Seo EJ; Lee SW; Suh JK; Im HJ; Seo JJ
J Korean Med Sci; 2014 Jul; 29(7):926-33. PubMed ID: 25045224
[TBL] [Abstract][Full Text] [Related]
7. Detection of copy number alterations in acute myeloid leukemia and myelodysplastic syndromes.
Jacoby MA; Walter MJ
Expert Rev Mol Diagn; 2012 Apr; 12(3):253-64. PubMed ID: 22468816
[TBL] [Abstract][Full Text] [Related]
8. The advantage of using SNP array in clinical testing for hematological malignancies--a comparative study of three genetic testing methods.
Xu X; Johnson EB; Leverton L; Arthur A; Watson Q; Chang FL; Raca G; Laffin JJ
Cancer Genet; 2013; 206(9-10):317-26. PubMed ID: 24269304
[TBL] [Abstract][Full Text] [Related]
9. Combining metaphase cytogenetics with single nucleotide polymorphism arrays can improve the diagnostic yield and identify prognosis more precisely in myelodysplastic syndromes.
Qin Y; Zhang H; Feng L; Wei H; Wu Y; Jiang C; Xu Z; Zhu H; Liu T
Ann Med; 2022 Dec; 54(1):2627-2636. PubMed ID: 36148999
[TBL] [Abstract][Full Text] [Related]
10. Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome.
da Silva FB; Machado-Neto JA; Bertini VHLL; Velloso EDRP; Ratis CA; Calado RT; Simões BP; Rego EM; Traina F
J Clin Pathol; 2017 May; 70(5):435-442. PubMed ID: 27836923
[TBL] [Abstract][Full Text] [Related]
11. Significance of genome-wide analysis of copy number alterations and UPD in myelodysplastic syndromes using combined CGH - SNP arrays.
Ahmad A; Iqbal MA
Curr Med Chem; 2012; 19(22):3739-47. PubMed ID: 22680919
[TBL] [Abstract][Full Text] [Related]
12. Single nucleotide polymorphism array-based karyotyping in acute myeloid leukemia or myelodysplastic syndrome with trisomy 8 as the sole chromosomal abnormality.
Hahm C; Mun YC; Seong CM; Han SH; Chung WS; Huh J
Acta Haematol; 2013; 129(3):154-8. PubMed ID: 23208021
[TBL] [Abstract][Full Text] [Related]
13. Array comparative genomic hybridization of peripheral blood granulocytes of patients with myelodysplastic syndrome detects karyotypic abnormalities.
Vercauteren SM; Sung S; Starczynowski DT; Lam WL; Bruyere H; Horsman DE; Tsang P; Leitch H; Karsan A
Am J Clin Pathol; 2010 Jul; 134(1):119-26. PubMed ID: 20551276
[TBL] [Abstract][Full Text] [Related]
14. [Progress of cytogenetic detection in myelodysplastic syndromes].
Zhou QB; Hu XM; Liu -; Ma R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1536-40. PubMed ID: 22169320
[TBL] [Abstract][Full Text] [Related]
15. Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis.
Huh J; Tiu RV; Gondek LP; O'Keefe CL; Jasek M; Makishima H; Jankowska AM; Jiang Y; Verma A; Theil KS; McDevitt MA; Maciejewski JP
Genes Chromosomes Cancer; 2010 Apr; 49(4):390-9. PubMed ID: 20095039
[TBL] [Abstract][Full Text] [Related]
16. High-resolution genomic arrays facilitate detection of novel cryptic chromosomal lesions in myelodysplastic syndromes.
O'Keefe CL; Tiu R; Gondek LP; Powers J; Theil KS; Kalaycio M; Lichtin A; Sekeres MA; Maciejewski JP
Exp Hematol; 2007 Feb; 35(2):240-51. PubMed ID: 17258073
[TBL] [Abstract][Full Text] [Related]
17. Clinical Applications of Chromosomal Microarray Testing in Myeloid Malignancies.
Ronaghy A; Yang RK; Khoury JD; Kanagal-Shamanna R
Curr Hematol Malig Rep; 2020 Jun; 15(3):194-202. PubMed ID: 32382988
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies.
Tiu RV; Gondek LP; O'Keefe CL; Elson P; Huh J; Mohamedali A; Kulasekararaj A; Advani AS; Paquette R; List AF; Sekeres MA; McDevitt MA; Mufti GJ; Maciejewski JP
Blood; 2011 Apr; 117(17):4552-60. PubMed ID: 21285439
[TBL] [Abstract][Full Text] [Related]
19. Myelodysplastic syndromes with del(5q): indications and strategies for cytogenetic testing.
Haferlach C; Bacher U; Tiu R; Maciejewski JP; List A
Cancer Genet Cytogenet; 2008 Dec; 187(2):101-11. PubMed ID: 19027491
[TBL] [Abstract][Full Text] [Related]
20. From cryptic chromosomal lesions to pathologically relevant genes: integration of SNP-array with gene expression profiling in myelodysplastic syndrome with normal karyotype.
Merkerova MD; Bystricka D; Belickova M; Krejcik Z; Zemanova Z; Polak J; Hajkova H; Brezinova J; Michalova K; Cermak J
Genes Chromosomes Cancer; 2012 May; 51(5):419-28. PubMed ID: 22250017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
